The burden of T1D globally is expected to increase rapidly between 2021 and 2040, according to a study published in The Lancet Diabetes & Endocrinology. Researchers developed a model to estimate T1D prevalence, incidence,...
For many clinicians who treat patients with psoriasis, achieving 2022 revenue goals has been challenging. London-based consulting firm Censuswide polled chief financial officers (CFOs) and revenue cycle vice presidents (VPs) in...